294 related articles for article (PubMed ID: 35087748)
21. [Application of preoperative serum CYFRA 21-1 level in the prognosis of colorectal cancer].
Hu WQ; Cong H; Fang RH; Yuan WT; Mao CY; Wang JR; Wang Y; Shi XY
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1613-1619. PubMed ID: 37859379
[TBL] [Abstract][Full Text] [Related]
22. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.
Ying HQ; Chen W; Xiong CF; Wang Y; Li XJ; Cheng XX
Cancer Cell Int; 2022 Mar; 22(1):137. PubMed ID: 35346200
[TBL] [Abstract][Full Text] [Related]
23. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.
Chen L; Jiang B; Wang Z; Liu M; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
Clin Transl Oncol; 2014 Mar; 16(3):285-92. PubMed ID: 23860725
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of postoperative longitudinal change of serum carcinoembryonic antigen level in patients with stage I lung adenocarcinoma completely resected by single-port video-assisted thoracic surgery: a retrospective study.
Chen H; Jiang Y; Jia K; Zhang K; Matsuura N; Jeong JY; Su B; Zhou X
Transl Lung Cancer Res; 2021 Oct; 10(10):3983-3994. PubMed ID: 34858786
[TBL] [Abstract][Full Text] [Related]
25. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
26. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer.
Zhou S; Sheng N; Ren J; He Q; Zhang Y; Gong J; Wang Z
Front Oncol; 2021; 11():741309. PubMed ID: 34692522
[TBL] [Abstract][Full Text] [Related]
28. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
[TBL] [Abstract][Full Text] [Related]
29. Clinical Associations of Preoperative and Postoperative Serum CEA and Lung Cancer Outcome.
Jiao Z; Cao S; Li J; Hu N; Gong Y; Wang L; Jin S
Front Mol Biosci; 2021; 8():686313. PubMed ID: 34778369
[No Abstract] [Full Text] [Related]
30. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
31. Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels.
Zhang C; Zheng W; Lv Y; Shan L; Xu D; Pan Y; Zhu H; Qi H
Transl Cancer Res; 2020 Jan; 9(1):111-118. PubMed ID: 35117164
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Neutrophil-BMI Ratio As a Promising New Marker for Predicting Tumor Outcomes in Colorectal Cancer.
Xie W; Huang X; Wei C; Mo X; Ru H; Zhang L; Ge L; Tang W; Liu J
Technol Cancer Res Treat; 2022; 21():15330338211064077. PubMed ID: 35225701
[No Abstract] [Full Text] [Related]
33. Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker.
Jeon BG; Shin R; Chung JK; Jung IM; Heo SC
Ann Coloproctol; 2013 Jun; 29(3):106-14. PubMed ID: 23862128
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
35. Clinical Significance of Early Carcinoembryonic Antigen Change in Patients With Nonmetastatic Colorectal Cancer.
Jo Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J
Front Oncol; 2022; 12():739614. PubMed ID: 35615159
[TBL] [Abstract][Full Text] [Related]
36. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
37. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
38. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
[TBL] [Abstract][Full Text] [Related]
39. Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study.
Li J; Mei S; Zhou S; Zhao F; Liu Q
J Gastrointest Oncol; 2022 Apr; 13(2):710-721. PubMed ID: 35557585
[TBL] [Abstract][Full Text] [Related]
40. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
Huang SH; Tsai WS; You JF; Hung HY; Yeh CY; Hsieh PS; Chiang SF; Lai CC; Chiang JM; Tang R; Chen JS
Ann Surg Oncol; 2019 Jun; 26(6):1685-1694. PubMed ID: 30915591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
